BRCA-related ovarian carcinoma

Bevacizumab plus fosbretabulin in recurrent ovarian cancer: Overall survival and exploratory analyses of a randomized phase II NRG oncology/gynecologic oncology group study.

Gynecologic oncology·2020

Randomized Trial of Intravenous Versus Intraperitoneal Chemotherapy Plus Bevacizumab in Advanced Ovarian Carcinoma: An NRG Oncology/Gynecologic Oncology Group Study.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2019

Correlation between Surgeon's assessment and radiographic evaluation of residual disease in women with advanced stage ovarian cancer reported to have undergone optimal surgical cytoreduction: An NRG Oncology/Gynecologic Oncology Group study.

Gynecologic oncology·2018

Preoperative predictors that impact the survival and outcome of patients undergoing secondary cytoreduction for ovarian cancer.

Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology·2018

Bevacizumab and paclitaxel-carboplatin chemotherapy and secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer (NRG Oncology/Gynecologic Oncology Group study GOG-0213): a multicentre, open-label, randomised, phase 3 trial.

The Lancet. Oncology·2017

CT Perfusion as an Early Biomarker of Treatment Efficacy in Advanced Ovarian Cancer: An ACRIN and GOG Study.

Clinical cancer research : an official journal of the American Association for Cancer Research·2017

Optimizing safety and efficacy of asparaginase and blinatumomab therapy in frontline acute lymphoblastic leukemia regimens in diverse health care settings-international expert consensus.

Cancer·2026

How low do you need to go? Association between various prostate-specific antigen response measures and clinical outcomes in metastatic castration-sensitive prostate cancer in the Veterans Health Administration data.

Cancer·2026

Relationship between bisphosphonate use and risks of recurrence and mortality among hormone receptor-positive and triple-negative breast cancer patients.

Cancer·2026

Sexual health behaviors and contraceptive practices among Canadian childhood, adolescent, and young adult cancer survivors and controls.

Cancer·2026

Assessment of safe chemotherapy handling behaviors among oncology nurses in a conflict-affected setting: A cross-sectional study from Gaza.

Cancer·2026

Hypofractionated preoperative radiotherapy for extremity soft tissue sarcoma: Are we racing ahead of the toxicity data?

Cancer·2026

Circadian Rhythms in Colorectal Cancer: Recent Advances in Development and Treatment.

Journal of clinical medicine research·2026

A Protocol for Colorectal Tumor Spheroid Culture in Tunable Stiffness Alginate-Based Hydrogels and Subsequent Immunohistochemical Analysis.

Bio-protocol·2026

Glioblastoma as a neuro-immune network disorder: rethinking the tumor microenvironment, neural circuit integration, and therapeutic resistance.

Oncology reviews·2026

Aging-related metabolic dysregulation in osteoporosis: mechanisms and therapeutic strategies.

Frontiers in aging·2026

Gut microbiota-derived butyrate and the SIRT1/FoxO1 axis: epigenetic-metabolic regulation of ovarian function in premature ovarian insufficiency-a comprehensive review.

Frontiers in microbiology·2026

Microbiome-Driven Mechanisms in Breast Cancer: Emerging Evidence From Gut Microbial Signatures to Therapeutic Response.

BioMed research international·2026

Related Experiment Videos

BRCA-related ovarian carcinoma

Related Concept Videos

Bevacizumab plus fosbretabulin in recurrent ovarian cancer: Overall survival and exploratory analyses of a randomized phase II NRG oncology/gynecologic oncology group study.

Randomized Trial of Intravenous Versus Intraperitoneal Chemotherapy Plus Bevacizumab in Advanced Ovarian Carcinoma: An NRG Oncology/Gynecologic Oncology Group Study.

Correlation between Surgeon's assessment and radiographic evaluation of residual disease in women with advanced stage ovarian cancer reported to have undergone optimal surgical cytoreduction: An NRG Oncology/Gynecologic Oncology Group study.

Preoperative predictors that impact the survival and outcome of patients undergoing secondary cytoreduction for ovarian cancer.

Bevacizumab and paclitaxel-carboplatin chemotherapy and secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer (NRG Oncology/Gynecologic Oncology Group study GOG-0213): a multicentre, open-label, randomised, phase 3 trial.

CT Perfusion as an Early Biomarker of Treatment Efficacy in Advanced Ovarian Cancer: An ACRIN and GOG Study.

Optimizing safety and efficacy of asparaginase and blinatumomab therapy in frontline acute lymphoblastic leukemia regimens in diverse health care settings-international expert consensus.

How low do you need to go? Association between various prostate-specific antigen response measures and clinical outcomes in metastatic castration-sensitive prostate cancer in the Veterans Health Administration data.

Relationship between bisphosphonate use and risks of recurrence and mortality among hormone receptor-positive and triple-negative breast cancer patients.

Sexual health behaviors and contraceptive practices among Canadian childhood, adolescent, and young adult cancer survivors and controls.

Assessment of safe chemotherapy handling behaviors among oncology nurses in a conflict-affected setting: A cross-sectional study from Gaza.

Hypofractionated preoperative radiotherapy for extremity soft tissue sarcoma: Are we racing ahead of the toxicity data?

Circadian Rhythms in Colorectal Cancer: Recent Advances in Development and Treatment.

A Protocol for Colorectal Tumor Spheroid Culture in Tunable Stiffness Alginate-Based Hydrogels and Subsequent Immunohistochemical Analysis.

Glioblastoma as a neuro-immune network disorder: rethinking the tumor microenvironment, neural circuit integration, and therapeutic resistance.

Aging-related metabolic dysregulation in osteoporosis: mechanisms and therapeutic strategies.

Gut microbiota-derived butyrate and the SIRT1/FoxO1 axis: epigenetic-metabolic regulation of ovarian function in premature ovarian insufficiency-a comprehensive review.

Microbiome-Driven Mechanisms in Breast Cancer: Emerging Evidence From Gut Microbial Signatures to Therapeutic Response.

Related Experiment Videos

BRCA-related ovarian carcinoma

Related Concept Videos

Related Articles